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COVID-19 is only partly understood, and the level of evidence available in terms of patho-
physiology, epidemiology, therapy, and long-term outcome remains limited. During the early
phase of the pandemic, it was necessary to effectively investigate all aspects of this new dis-
ease. Autopsy can be a valuable procedure to investigate the internal organs with special
techniques to obtain information on the disease, especially the distribution and type of organ
involvement.
Methods
During the first wave of COVID-19 in Germany, autopsies of 19 deceased patients were per-
formed. Besides gross examination, the organs were analyzed with standard histology and
polymerase-chain-reaction for SARS-CoV-2. Polymerase chain reaction positive localiza-
tions were further analyzed with immunohistochemistry and RNA-in situ hybridization for
SARS-CoV-2.
Results
Eighteen of 19 patients were found to have died due to COVID-19. Clinically relevant histo-
logical changes were only observed in the lungs. Diffuse alveolar damage in considerably
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different degrees was noted in 18 cases. Other organs, including the central nervous sys-
tem, did not show specific micromorphological alterations. In terms of SARS-CoV-2 detec-
tion, the focus remains on the upper airways and lungs. This is true for both the number of
positive samples and the viral load. A highly significant inverse correlation between the
stage of diffuse alveolar damage and viral load was found on a case and a sample basis.
Mediastinal lymph nodes and fat were also affected by the virus at high frequencies. By con-
trast, other organs rarely exhibited a viral infection. Moderate to strong correlations between
the methods for detecting SARS-CoV-2 were observed for the lungs and for other organs.
Conclusions
The lung is the most affected organ in gross examination, histology and polymerase chain
reaction. SARS-CoV-2 detection in other organs did not reveal relevant or specific histologi-
cal changes. Moreover, we did not find CNS involvement.
Introduction
COVID-19, which emerged at the end of 2019, is only partly understood, and the level of evi-
dence available in terms of pathophysiology, epidemiology, treatment, and long-term out-
comes is limited. During the early phase of the pandemic, the clinical course of this novel
infectious disease was found to differ from that of other viral infections such as influenza.
COVID-19 presents more frequent with severe illness accompanied with lung injury which
results more often in fatal course, and also SARS-CoV-2 seems to be more contagious and vir-
ulent than influenza [1–3]. Given the high numbers of critically ill patients, it became neces-
sary to establish an effective approach to investigate all the aspects of this new disease. Autopsy
rates declined dramatically over the last decades, but it can offer the opportunity to directly
inspect all organs, identify the cause of death, and generate specimens for further investiga-
tions [4]. And this is true for COVID-19 as well, a new disease still not yet understood in detail
and lack of sufficient therapeutic approach. Therefore, the aim was to analyze the macroscopic,
microscopic changes and the spread of the virus in the deceased patients for the first step and
to generate tissue and liquid samples for further investigations in terms of mechanisms of the
disease. After overcoming initial restrictions regarding performing autopsies in cases of
COVID-19, especially in Europe, several pathologists and forensic scientists of different
departments started structured activities in this direction [5–8]. The main finding from autop-
sies is diffuse alveolar damage (DAD) [9, 10]. The lung changes occur independently of the
performance of invasive ventilation [11]. In addition, reports of thromboembolic events at dif-
ferent levels—ranging from microthrombi to fulminating macroembolism with extensive
organ infarction [12]. Varga et al. first proposed endothelialitis as a cause of this increased
coagulation propensity [13]. Renal damage has also been described in detail [14]. However,
the findings related to the central nervous system (CNS) have been contradictory and do not
yet provide sufficient evidence for direct brain damage by SARS-Cov2, except for involvement
in systemic coagulation.
Here, we present a series of 19 postmortem examinations of COVID-19 patients with com-
plete gross examination in most cases and analysis of organs, including the CNS. We con-
ducted a comprehensive approach for multimodal viral mapping within the organism
applying different methods: immunohistochemistry (IHC), real-time quantitative polymerase
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chain reaction (RT-qPCR), and RNA-in situ hybridization (RNA-ISH) (positive/plus and neg-
ative/minus sense). Additionally, we evaluated the correlation of DAD with viral load in the
lungs and with clinical parameters.
Methods and materials
Cohort
From April 4 to May 13, 2020, 19 autopsies (15 full and 4 limited) were performed. 18 patients
died at the University Medical Center Augsburg (UKA), representing 86% of all Covid-19
deceased at the UKA during the first wave of the pandemic. Only one patient was treated
and died in a community hospital outside Augsburg. All cases were tested positive for SARS-
CoV-2 with nasopharyngeal swabs during the clinical course.
According to national rules after the death of the patient and before autopsy, informed con-
sent for the autopsy including research issues was obtained verbal by next of kin and docu-
mented in the patient´s record. Due to restricted consent in four cases, only limited autopsy
with removal of parts of the lung, liver, kidney, spleen was performed. In these cases, also no
CNS specimens could be collected. Clinical data (including medical history, comorbidities,
medication, and treatment) of all persons who died were obtained from the electronic medical
records. This study was approved by the internal review board of the UKA (BKF No. 2020–18)
and the ethics committee of the University of Munich (Project number 20–426, COVID-19
registry of the UKA). Ten of 19 cases were already included in a previous [11].
Autopsy
Depending on the consent, a conventional full autopsy or limited organ removal or biopsy was
performed. Special attention was paid to the safety of personnel, as described in the previous
study [15]. During inspection of the opened body cavities, particular attention was paid to
effusion formation, hemorrhage, and signs of thromboembolic events. First, all removed
organs (such as the lungs, heart, liver, spleen, kidneys, and brain) were inspected macroscop-
ically, weighted, and measured. Next, they were immediately stored and fixed in buffered 10%
formalin. For better fixation, the lungs were flushed with formalin by syringe injection. After
at least 10 days of fixation, representative formalin-fixed and paraffin embedded samples
(FFPE) were generated. During autopsy, swabs of different sides of the respiratory tract (the
throat, trachea, and bronchus) were performed, and samples of CSF and pleural, peritoneal, or
pericardial effusion (if present) were analyzed. In the cases of partial autopsies, in situ exami-
nations of the lungs were performed and large biopsies of at least 8 cm in diameter were
obtained.
Histology and IHC (http://dx.doi.org/10.17504/protocols.io.bvvwn67e, S1
File)
From all FFPE blocks, hematoxylin and eosin (H&E)-stained slides for histological analysis
were produced. Additionally, immunhistological staining for SARS-CoV-2 was performed
from representative lung samples of the left and right lobes and from all samples with a SARS-
CoV2-positive PCR test (see below). A monoclonal SARS N-specific antibody was used
(4F3C4, 1:200, Institute of Virology, University of Leipzig, Leipzig, Germany) [16] and all
steps were performed manually. The slides were deparaffinized and rehydrated in xylene and
ethanol in decreasing concentrations. The endogenous peroxidase was deactivated with 3%
hydrogen peroxide. For antigen retrieval, microwave treatment (700 W, 20 min) was used.
Unspecific binding was blocked using goat serum. The primary antibody was incubated
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overnight at 4˚C, the secondary antibody (goat antimouse biotin, 1:200, Vector laboratories,
Peterborough, UK) was incubated for 30 min followed by incubation with the avidin–biotin
complex for another 30 min. AEC-substrate chromogen was used to develop the staining reac-
tion (Agilent-Dako, Waldbronn, Germany). The slides were counterstained with hematoxylin
(Morphisto, Frankfurt, Germany). On-slide positive controls were selected from samples with
positive virus detection and low CT values (� 25) and mounted on each slide.
All slides were evaluated by an experienced board-certified pathologist (TS). Based on the
information obtained from this evaluation, particularly the extent of change seen, representa-
tive slides were selected and independently analyzed and classified by TS and another experi-
enced board-certified pathologist (BM). Both of whom were blinded to the cases’ clinical
history. Discrepancies were resolved by mutual consensus. The histological analyses included
the categorical assessment of several features in different organs. The categories were either
dichotomous (not present/present) or four tiered (none, mild, intermediate, and strong).
Immunohistochemical semiquantitative evaluation of SARS-CoV-2 was performed in a repre-
sentative sample from each lobe of the lungs and in all samples of organs other than lungs with
a positive result in the RT-qPCR. It was conducted by categorizing it into four groups: negative
(no positive cells), low (a single or a few cells scattered in a low density), intermediate (strongly
positive cells in a cluster of at least 5 mm diameter or weak/moderately positive in many cells
throughout the sample), and high (many strongly positive cells throughout the sample).
RT-qPCR (http://dx.doi.org/10.17504/protocols.io.bvvxn67n, S2 File)
RNA was extracted from 3 x 8-μm slices of FFPE tissue sections from all organs by using the
Promega Maxwell1 16 MDx system and the Promega Maxwell 16 LEV RNA FFPE Purifica-
tion Kit following the manufacturer’s instructions (AS1260, Promega Corporation, Madison,
WI, USA).
Quantitative real-time PCR for SARS-CoV-2 was performed on extracts with one-step mul-
tiplex RT-qPCR targeting the SARS-CoV-2 ORF1ab, N Protein, and S Protein using the Taq-
Path COVID-19 CE-IVD RT-PCR Kit (A48067, Thermo Fisher, Pleasanton, TX, USA).
Briefly, 5 μL of the extract was amplified in 25 μL of the reaction mixture containing 6.25 μL of
TaqPath 1-Step Multiplex Master Mix, 1.25 μL of COVID-19 Real-Time PCR Assay Multiplex,
and 12.5 of μL nuclease-free water, following the manufacturer’s instructions. The RT-qPCR
was run on the QuantStudio 5 Dx real-time PCR Instrument and data were analyzed and inter-
preted by QuantStudio™ design and analysis software (v.1.2x, Thermo Fisher, Carlsbad, CA,
USA). As an extraction control, 10 μL MS2 phage control was added to the extraction and was
used as a negative control in qPCR. The positive control was supplied by the TaqPath
COVID-19 CE-IVD RT-PCR Kit. Results with two or more positive targets were described as
valid.
The cycle-threshold (Ct) values were classified into seven categories (10–15; 16–20; 21–25;
26–30; 31–35; 36–40; negative).
RNA-ISH (http://dx.doi.org/10.17504/protocols.io.bvvun66w, S3 File)
For the in-situ hybridization for SARS-CoV-2 on the FFPE materials of the lung specimens,
two probes were used to detect infected cells and identify replicating viruses (positive/plus-
and negative/minus-sense). Positive and negative controls were integrated to verify the cor-
rectness of the staining results (RNAscope Probe–V-nCoV2019-S and V-nCoV2019-S-sense,
Positive Control Probe–Hs-UBC, Advanced Cell Diagnostics, Germany) RNAscope 2.5 HD
Assay-RED kit (Advanced Cell Diagnostics, Germany) was used for realizing the hybridization
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of the probes and its visualization according to the manufacture’s protocols by manual tech-
nique on 5 μm thick FFPE sections.
RNA-ISH evaluation was performed on the same samples (lungs in all patients and for
other organs, which were tested positive by RT-qPCR) as the immunohistochemical SARS-
CoV-analysis. The classification scheme was also identical.
Correlation of DAD with clinical parameters
As there are established or discussed clinical parameters and patient characteristics influencing
the outcome of COVID-19, we aimed to correlate those parameters with the DAD stage.
Therefore, we chose parameters which seems to be relevant from the clinical point of view and
which were available for all 19 patients: Sex, age, smoking history, BMI, diabetes, numbers of
comorbidities and length of ventilation.
Statistical analysis
Correlations between Ct values and histological parameters, as well as the different RNA detec-
tion methods, were calculated using the Spearman rank order correlation. We calculated the
Pearson correlation between DAD and several parameters of viral load in the lungs as well as
clinical parameters. To detect the impact of clinical variables on DAD, we performed linear
regression models and adjusted for potentially confounding variables through multiple linear
regression models. All tests were two-sided, and p< 0.05 was set as significant. All analyses
were conducted with free software environment for statistical computing and graphics R ver-
sion 4.0.2 and Sigma plot 13.0 (Systat Software, San Jose, CA, USA).
Results
Cohort and clinical data
The median age of the 19 patients (5 women and 14 men) at the time of death was 73 years
(range: 57–90 years). The patients had a median of four known preexisting comorbidities
(range: 0–9), with cardiovascular disease being most frequent. Table 1 summarizes the
patients’ basic characteristics.
The most frequent initial symptoms included fever, cough, and dyspnea. During the clinical
course, 15 patients were transferred to the intensive care unit. Nine of them required intuba-
tion and invasive ventilation, and five required noninvasive ventilation. In four cases, therapy
was limited at the patient’s request and intensive medical treatment was not initiated. A clini-
cally diagnosed acute respiratory distress syndrome (ARDS) was reported in 16 patients. The
median time from admission to death was 11 days (range: 1–36 days), and the median time
between death and autopsy was 26 h (range: 6–53 h). Detailed information on clinical course
and treatment is presented in Table 2.
Autoptic macroscopical findings and histology
Lungs. Macroscopically, the lung tissue showed at least edema and slight redness, but
most of them were markedly consolidated, hemorrhagic, and severely edematous and friable.
These changes were accentuated in the lower lobes but were usually at least to some extent as
well present in the other lobes. In one patient, extensive areas of sclerosis were observed on the
parasagittal plains.
A total number of 680 slides from the lungs were screened, and 83 representative slides
were selected by TS for the semiquantitative analyses that was conducted by TS and BM.
Despite being obtained from autopsies, the histology was excellently preserved in most cases
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with autolytic changes in the small minority only. Changes in DAD in considerably different
degrees were observed in 72 of 83 available specimens from the lung lobs in all but one of the
19 cases (Fig 1). In this single case, only the right upper lope was affected by an acute DAD.
The early stage (the highest stage in three cases), in addition to interstitial and intraalveolar
edema, was characterized by hyaline membranes. Partly, a slight blood vessel congestion and
swelling of the pneumocytes were appreciable. In the stage of organization (the highest stage
in 15 cases), there was a broadening of alveolar septa and desquamation of pneumocytes. Mac-
rophages were found mainly intraalveolar, whereas giant cells and lymphoplasmacytic inflam-
matory infiltrate of varying densities were found in the interstitial tissue and partly with
perivascular accentuation. Furthermore, there was clear fibroblastic proliferation. In some sec-
tions, squamous, and osseous metaplasia were noted. In the late stage (so-called end-stage
DAD; the highest stage in one case), the lung tissue shows scarring fibrosis and no longer an
inflammatory infiltrate. Microthrombi were identified in 14 slides (17%) of 10 cases (53%).
Areas with considerable vascular congestion and hemorrhage were observed in 30 (36%) slides
in 11 (58%) cases.
Heart, liver, kidney, spleen, lymph nodes, mediastinal fat. 790 slides from organs other
than the lungs and the CNS have been screened as described above. 134 of those have been
selected for the semiquantitative evaluation.
On the basis of macroscopy and conventional light microscopy of H&E-stained slides,
organs other than the lungs did not show any specific macroscopic or histological
Table 1. Preexisting patients’ basic characteristics.
Variable No.
Total number of patients 19 (100%)
Mean/Median Age (range) 74/73 years (57–90)
Sex (male/female) 14 (74%) / 5 (26%)
Smoker (yes/no) 7 (37%) /12 (63%)
Comorbidities
Median number (range) 4 (0–9)
Cardiovascular 13 (68%)
Atrial fibrillation 11 (58%)
Coronary artery disease 5 (26%)
Cardiomyopathy 5 (26%)






Median body mass index (range) 28.3 kg/m2 (19.6–66.2)
Chronic respiratory disease 5 (26%)
Chronic renal disease 7 (37%)
Hyperlipoproteinemia 4 (21%)
Prevalent malignancies 3 (16%)
Therapeutics
Angiotensin converting enzyme inhibitors 9 (47%)
Angiotensin II receptor blockers 2 (11%)
CLL = chronic lymphatic leukemia, CMML = chronic myelomonocytic leukemia
https://doi.org/10.1371/journal.pone.0254872.t001
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abnormalities that would differ in type, extent, and frequency from autopsies of other deceased
of the same age with similar previous diseases (for example, steatosis hepatitis, arteriosclerosis,
vascular damage of the kidney). Frequently found changes were related to cardiovascular
changes: cardiomyopathy, coronary heart disease (two cases with old myocardial infarction),
and general arteriosclerosis. Hepatic changes included steatosis and fibrotic changes accompa-
nied by mild portal inflammation. Relevant kidney changes were also arteriosclerosis related.
Despite rapid fixation, examination of the renal tubular system was hampered due to autolytic
changes.
Table 2. Clinical course and treatment.
Variable No.





Worsening general condition 9 (47%)
Diarrhea 1 (5%)
Median time between onset of symptoms and admission� (range) 5 days (0–21)
Radiologic findings (CT = 4, X-Ray = 15)
Bilateral patchy shadowing 16 (84%)
Ground-glass opacity 2 (11%)
Respiratory findings
Median Horowitz index� (range)) 107 mmHg (50–150)
Acute respiratory distress syndrome 16 (84%)
Septic shock 7 (37%)
Acute kidney injury 14 (74%)
Congestive heart failure 13 (68%)
Clinical diagnosed pneumonia 8 (42%)
Thromboembolic events (DVT/PE) 2 (11%)
Systemic therapy
Systemic glucocorticoids (hydrocortisone for septic shock) 3 (16%)
Remdesivir 0 (0%)
Chloroquine or Hydroxychloroquine 8 (42%)
Reconvalescent plasma 3 (16%)
Intravenous antibiotics 17 (89%)
Median number of antibiotic substances (range) 2 (0–8)
Anticoagulation use
Deep venous thrombosis prophylaxis 9 (47%)
Full dose anticoagulation 10 (53%)
Vasopressors 10 (53%)
Ventilation
Oxygen only 5 (26%)
Noninvasive 5 (26%)
Invasive 9 (47%)
Renal replacement therapy 5 (26%)
�Missing information in three cases
CT = computed tomography, DVT = deep vein thrombosis, PE = pulmonary embolism
https://doi.org/10.1371/journal.pone.0254872.t002
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CNS. 225 samples of the autopsy of the brains, which was performed in 15 of the 19 cases
showed no distinct changes of viral-mediated encephalitis or vasculitis within these samples
from all parts of the brain and the spinal cord. The main findings were brain edema, hyperten-
sive angiopathy, and arteriosclerosis. In one case, an old media infarction was found. Another
case showed multiple fresh hemorrhages with hypoxic ganglion cell damage, and two areas of
older infarctions–again, these events were not considered to have caused death.
Causes of death. According to WHO guidelines [17], 18 of 19 patients died due to
COVID-19, and one died due to acute heart failure with underlying coronary artery disease,
cardiomyopathy, and atrial fibrillation. Only very limited DAD was noted in the lungs (acute
DAD in just one lobe in a limited area) in this case.
In 12 cases, death in the context of respiratory insufficiency with the presence of relevant
DAD was to be assumed on the basis of the changes seen at autopsy and in consideration of
the clinical data, in some cases combined with marked myocardial predamage. In the four par-
tial autopsies, no definite cause of death was identified, but the combination of DAD and clini-
cal data and course suggested death due to respiratory insufficiency. One patient died of
hemorrhagic shock due to extensive hemopneumothorax with hemorrhage into the lungs on
the floor of the extensive changes of the preceding COVID-19 pneumonia. Only one patient
died due to thromboembolic events (mesenteric ischemia of the small intestine and fulminant
Fig 1. Distribution of DAD based on 83 samples from 19 patients. DAD = diffuse alveolar damage.
https://doi.org/10.1371/journal.pone.0254872.g001
PLOS ONE Full organ mapping of patients with COVID-19: An autopsy study
PLOS ONE | https://doi.org/10.1371/journal.pone.0254872 July 19, 2021 8 / 21
pulmonary artery embolism) in the context of the COVID-19 infection, accompanied by rele-
vant signs of organizing DAD in three lobes.
Viral mapping of the organs. Mapping of the results of RT-qPCR, RNA-ISH, IHC, and
histology of all organs, together with basic demographic data, are illustrated in Fig 2. Upon
this basis, all further analyses were performed.
Distribution of SARS-CoV-2 by RT-qPCR and correlation with histological changes.
In total, 362 samples (51 swabs, 32 body fluids, and 279 tissues) from 24 locations were tested
for SARS-CoV2 with RT-qPCR to investigate the virus’s spread and distribution within the
organism. Altogether RT-qPCR revealed a positive result for SARS-CoV2 in 98 samples (32%).
At autopsy, the swabs were positive for SARS-CoV2-PCR in 15/19 cases (mean Ct-value
and standard deviation (SD): 23.6 ± 5.9) from the pharynx, in 13/16 cases (mean Ct-value and
SD: 25.5 ± 4.9) from the trachea, and in 11/16 cases (mean Ct-value and SD: 26.0 ± 5.8) from
bronchus. The categorized Ct values of these swabs correlated strongly with those of the lungs
(R> 0,82, p< 0.0001).
Pleural effusions were present in nine cases, five of which tested positive for SARS-CoV-2
by PCR (mean Ct-value and SD: 25.5 ± 4.9). Pericardial effusion was present in four cases, of
which one was positive (Ct-value: 25.9). Peritoneal effusion was positive in one of three cases
(Ct-value: 29.7). All 15 cerebrospinal fluid (CSF) samples were negative.
The distribution of SARS-CoV2 within the tissue samples evaluated using RT-qPCR is pre-
sented in Figs 2 and 3. The infection was mainly distributed in the upper airways and the
lungs. This is true for both the number of positive samples and the viral load demonstrated by
low Ct values. This was followed by intrathoracic locations (mediastinal lymph nodes and fat),
which were affected by the virus in high frequencies (� 60%) with low measured Ct values.
The heart, coronary artery, central arteries liver, kidney, and spleen rarely exhibited a viral
infection.
RT-qPCR-based analyses were performed on 60 samples from 15 brains with only one loca-
tion revealing positivity at the bulbus olfactorius with a high Ct-value of 31. No histological
changes were identified in this sample.
A significant inverse correlation was noted between stage of DAD (early, organizing, end-
stage) and RT-qPCR Ct values on a case basis (R = -0.69, p = 0.001) and sample basis (R =
-0.41, p< 0.001) (Fig 4A). On the level of cases and samples, significant correlations were also
seen between interstitial lymphocyte infiltration and DAD (R = 0.47, p = 0.04 and R = 0.44,
p< 0.001) but not with the RT-qPCR results. Moreover, Ct values did not correlate with peri-
vascular lymphocyte infiltration (R = 0.09, p = 0.41), diffuse hemorrhage (R = - 0.128,
p = 0.248), and microthrombi (R = -0.121, p = 0.274), nor did these histological factors corre-
late with each other (Fig 4B). In all other organs or regions, including trachea/ bronchi, liver,
kidneys, spleen, mesenterial fat, and lymph nodes, large arteries, only the heart samples
showed a highly significant correlation between mild inflammation in the epicardial region
and PCR-based viral detection (R = 0.828, p< 0.001).
Distribution of SARS-CoV-2 by RNA-ISH and IHC and correlation of the methods.
Besides RT-qPCR, SARS-CoV-2 infection of the organs was evaluated with in situ hybridiza-
tion using RNA-ISH and IHC in representative samples from all lung lobes and in RT-qPCR-
positive tissue samples outside of the lung.
In the lung sample, in addition to the positive-sense RNA, the negative-sense RNA was
evaluated to identify the replicable virus by RNA-ISH. Representative images are shown in Fig
5. The analysis showed moderate to strong correlations between the four methods (R: 0.43–
0.83, P: 0.06 to<0.001) with the highest positivity rate for RT-qPCR in 13 of 19 (68%) versus
10 (53%) positive cases in RNA-ISH positive-sense analysis and lowest rates in RNA-ISH nega-
tive-sense (3 of 19, 16%) and IHC (4 of 19, 21%) (Fig 4B). None of the six negative cases by
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Fig 2. Organ mapping of virus positivity by different techniques. PCR = real—time quantitative polymerase chain
reaction, RNA-ISH = RNA-in situ hybridization, IHC = immunohistochemistry, PLI = perivascular lymphocyte
infiltration, ILI = interstitial lymphocyte infiltration, DAD = diffuse alveolar damage, ULL = upper left lobe,
LLL = lower left lobe, LRL = lower right lobe, URL = upper right lobe, MRL = middle right lobe, CNS = central
nervous system, CSF = cerebrospinal fluid); The category Histology represents lymphoplasmacellular inflammation of
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RT-qPCR indicated a positive result using the other methods. To classify the viral affected cells
in the lungs, IHC-double-staining have been performed. It could be shown that the main
affected cells are pneumocytes with distinct nuclear expression of TTF-1 and perinuclear iden-
tification of viral protein (Fig 5). Next to that CD68-positive histocytes were also infected but
at a lower frequency.
Sixty-one samples from other organs, confirmed positive by RT-qPCR, were parallel evalu-
ated using RNA-ISH positive-sense and IHC with positivity rates of 49% (n = 30) and 28%
(n = 17).
Correlation of DAD with clinical parameters. We further evaluated the correlations
between DAD and clinical parameters. We found no correlation between DAD and age, smok-
ing history, and BMI. Further, the number of comorbidities (p = 0.066) and the length of venti-
lation (p = 0.087) indicated a slightly not significant trend for a correlation with DAD. Sex
(p = 0.036) and diabetes (p = 0.040) were the only variables that were correlated with DAD.
DAD was 1.3 points higher in mean for men than for women, whereas diabetes reduced DAD
by 1.2 points compared with nondiabetic patients.
We further fitted a multiple linear regression model with diabetes and sex which were both
significant. Here, DAD was 1.5 points higher in men than in women (SE: 0.5, p = 0.004) and
was decreased by 1.4 points for patients with diabetes (SE: 0.4, p = 0.005).
To determine the impact of these variables on DAD adjusted for other variables, we added
the number of comorbidities and length of ventilation to the model. In this model sex and dia-
betes remained the only significant variables.
Discussion
To the best of our knowledge, this is the first report of a COVID-19 autopsy series providing
multiorgan SARS-CoV-2 mapping, including body fluids, with systematic histology, IHC,
the respective organ system, regardless of the compartment in a four tired quantification. Thrombi are classified as
being present or absent.
https://doi.org/10.1371/journal.pone.0254872.g002
Fig 3. Detection of SARS-CoV-2 in the different organs by RT-qPCR on a sample basis. A) Positivity rata and
distribution. B) Ct value categories. ULL = upper left lobe, LLL = lower left lobe, LRL = lower right lobe, URL = upper right
lobe, MRL = middle right lobe, CNS = central nervous system, CSF = cerebrospinal fluid, qPCR = real-time quantitative
polymerase chain reaction.
https://doi.org/10.1371/journal.pone.0254872.g003
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Fig 4. A) Correlation of DAD stage and RT-qPCR Ct values (Boxplot/Bean-plot) and B) Correlation of histological lung changes
and RNA-detection with RT-qPCR and RNA-ISH and IHC on a sample basis. DAD = diffuse alveolar damage, qPCR = real-time
quantitative polymerase chain reaction, ct = cycling threshold, IHC = immunhistochemistry, PLI = perivascular lymphocyte
infiltration, ILI = interstitial lymphocyte infiltration.
https://doi.org/10.1371/journal.pone.0254872.g004
Fig 5. Representative microscopic images. A) H&E–Lung sample (case 8) with an early DAD with broad hyaline membranes,
broadening of the alveolar septa, and mild lymphocytic inflammation. B) RNA-ISH positive-sense–same case as A); remarkable
extensive SARS-CoV-2 detection in pneumocytes and interstitium. C) RNA-ISH negative-sense–the same case as A); negative -sense
RNA is observed only in a few cells. F) H&E and G) RNA-ISH positive-sense; Conventional staining shows a normal mucosa with well-
preserved respiratory epithelium. Detection of single infected cell with RNA-ISH. H) H&E and I) RNA-ISH positive-sense; Sclerosed
gleomerulus with several infected cells. J) H&E and K) RNA-ISH positive-sense; Adipose tissue with mild hemorrhagic alteration but
without relevant inflammation. High magnification of this slide reveals a single SARS-CoV-2 positive cell representation probably a
histiocyte.
https://doi.org/10.1371/journal.pone.0254872.g005
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RT-qPCR, and RNA-ISH examinations [18]. This comprehensive approach to investigating
many relevant organ systems within one study enables direct comparisons with a constant
diagnostic setting that is not influenced by differing protocols or assays.
Cohort
This study’s collective represents 86% of all deceased with known SARS-CoV-2 infection in
the time between April and May 2020 at University Medical Center Augsburg. One case came
from a clinic outside Augsburg city and district. The pandemic situation was rather moderate
at that time (7day incidence of max. 35/100,000) compared with other regions of Bavaria. The
mean age in this cohort was lower (75 vs. 81 years) with a more male-predominant sex distri-
bution (79% vs 53%) than the national data provided by the Robert Koch Institute [19]. This
difference might be relevant because there are well-known sex-related differences of COVID
[20, 21]. Our data also indicate that the women had a lower DAD stage than men. Other
authors, however, could not identify any difference, at least for end-stage DAD [22]. Variants
of concern [23] were not seen in Germany within the timeframe of this study. Sequencing of
the virus was performed in five cases and revealed genome stability within the individual’s
respiratory tract (submitted for publication).
Methods
In addition to H&E histology, we analyzed the tissue samples for SARS-CoV-2 by RT-qPCR,
RNA-ISH, and IHC. In lung samples, in addition to the positive-sense RNA, the negative-
sense RNA was targeted, indicating replication activity of SARS-CoV-2. In concordance with
the literature, conventional histology did not reveal any virus-specific changes as noted in
other viral infections, such as cytomegalovirus or herpes [18, 24]. RT-qPCR revealed viral
RNA at a high frequency and can be assumed as very sensitive. The subsequently performed
analyses using RNA-ISH and IHC identified viral RNA or protein with a specificity of 100%,
but with substantially lower sensitivities in between 23% (IHC and RNA-IHC negative-sense)
and 77% (RNA-ISH positive-sense) of the PCR-positive samples. Roden et al. recently reported
a high sensitivity for droplet digital PCR and a considerably lower sensitivity by RNA-ISH and
IHC of approximately one-third, which is comparable to our results [25]. On the basis of RT-
qPCR as the gold standard, Massoth et al. compared RNA-ISH and IHC for the detection of
this virus in 58 autoptic FFPE samples from different tissues. With sensitivity rates between
53% and 87%, their results are superior to ours [26]. These differences are likely due to techni-
cal differences in the protocols. First, we did not use automated platforms for RNA-ISH and
IHC. Second, a different noncommercial antibody was used for IHC because of its very distinct
staining results, resulting in reliable evaluability. In contrast to other reports, we identified no
unspecific staining [18]. Because of the known difficulties of electron microscopy using
autopsy material and the challenges of identifying the virus with certainty and the controver-
sial debate regarding published electron microscopy results in the field of COVID-19, we
decided not to initiate electron microscopy–related investigations [27, 28]. In concordance
with other authors, we conclude that RT-qPCR is a highly sensitive and robust technique for
screening for SARS-CoV-2 in tissues and liquid samples. It requires moderate technical efforts
and is relatively cost effective. RNA-ISH is superior in terms of determining the exact localiza-
tion of the virus and the tying of the affected cells, whereas IHC has lower cost and wider avail-
ability. The low sensitivity and low specificity of at least some antibodies hamper the benefits
of this method.
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DAD
In this study, we noted severe changes in the lungs in all cases. Eighteen cases exhibited high
grades of typical histological features of DAD. Only one case had relatively mild DAD changes,
restricted to the left upper lobe. As mentioned earlier, this morphological change of COVID-
19 has been confirmed in many reports [9–11, 24, 29–31]. DAD stages correlated inversely
with the viral load (Fig 4). No correlations were identified for the extent of interstitial and peri-
vascular lymphocytic infiltration or for the occurrence of microthrombi or diffuse hemor-
rhage. To the best of our knowledge, this is the only study to investigate such relations.
Viral mapping
The viral infection within the body showed a strong accentuation within the upper airway and
the lungs. Many authors have recently reported viral detection within the respiratory system
[9, 10, 12, 24, 29–34]. Interestingly, a strong positive correlation of RT-qPCR between lung tis-
sue and the swabs of throat, trachea, and bronchus was given. In only one of four negative pha-
ryngeal swabs, the RT-qPCR testing of the lungs revealed a positive result. Despite the fact of
viral spreading from the upper to lower airway, the virus or at least parts of the virus remain
detectable in the upper airway at the time of death. Skok et al. reported almost identical results
[34] relativizing the opposing results of some case and small series reports in this regard [35–
37]. Our cohort’s lower airways showed less often a positive ISH signal for negative-sense
RNA in correlation to positive-sense RNA (3 vs. 13, 23%), indicating that not all detectable
virus by RT-qPCR remains active. Massoth et al. reported a rate of two of 5 (40%) with positiv-
ity for the positive and negative-sense RNA. Interestingly, they reported negative-sense RNA
by total RNA-seq in four of five cases, indicating a much higher sensitivity of sequencing.
Interestingly, mediastinal fat was infected at a high frequency with low Ct values. RNA-ISH
revealed positive and negative-sense RNA that makes contamination unlikely. On the other
hand, adipose tissue has a high density of the ACE-2-receptor [38, 39]. Together with spatial
proximity, this may explain the unexpected high viral load. In the relatively rare cases of virus
identification in heart samples, it was always found in the epicardial fat, not the myocardium.
This agrees with other reports speculating epicardial fat’s proinflammatory role in COVID-19
[40, 41]. Mediastinal lymph nodes showed viral infection at a high frequency, with RNA iden-
tification in almost 70% by RT-qPCR and 25% by RNA-ISH. An identical positivity rate by
RT-qPCR was reported by Haslbauer et al. [42]. Other organs of the thoracal cavity were
affected at a lower frequency and with a lower viral load. The evaluation of the heart (endo-,
myo- and epicardium) revealed viral RNA in 3 of 16 samples (19%) by RT-qPCR and in 2 of
those 3 also by RNA-ISH. These results are in between the findings of Bois et al., with no viral
detection by droplet PCR (n = 15) [43] and the meta-analysis of Roshdy et al., with 47% (50 of
105) [44]. We paid special attention to heart valves and coronary arteries. The valves showed
viral involvement at a similar frequency as the heart samples. Coronaries were involved in 4 of
13 (31%) samples. The three sample locations of the cardiac system did not correlate with each
other regarding viral involvement.
Compared with the thoracal cavity, the involvement of the organs and structures of the
peritoneal cavity and retroperitoneal space was considerably lower. The liver samples in our
series were positive for SARS-CoV-2 in 22% (4 of 18) by RT-qPCR, whereas RNA-ISH and
IHC revealed no positive case. Considerably higher positivity rates were reported by other
authors, between 55% and 88% [24, 31, 45]. Given the high density of ACE receptors in the
renal parenchyma, involvement by SARS-CoV2 was of particular interest at the beginning of
the pandemic [33]. Nevertheless, whether direct infection or indirect effects are the main cause
of renal dysfunction remains unclear [46]. The viral positivity rate in our series was 21% (3 of
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14) by both RT-qPCR and RNA-ISH. In the largest series published so far, Braun et al. pre-
sented a higher rate of 60% (38 of 63 patients) [47]. The spleen, as another large lymphatic
organ, shows a significantly lower viral load in the deceased compared with mediastinal lymph
nodes. In only 3 of 14 spleens, viral RNA was identified by RT-qPCR with high to intermediate
Ct values. Other authors have reported in series between 3 and 16 cases rates of splenic viral
detection, ranging from 10% to 100% [24, 30, 31, 48]. The comparison with the mediastinal
lymph nodes indicates that the detection of SARS-CoV-2 does not depend on the tissue type
but on direct lymphatic drainage.
PCR analysis of brain tissue was performed in 15 cases. In only one case, PCR was positive,
with a very high Ct-value. The rates in other published studies so far vary from our experience.
Serrano et al. showed a frequency of viral detection in 20% of cases [49]. Analyzing the results
of 28 autopsy studies, Li et al. reported a mean frequency RNA-based virus detection of 33% in
93 cases [8]. The rate of positivity, regardless of the method, was calculated to be 52%. The rate
of viral detection in the cerebrospinal fluids of 468 patients was 6.4% [8]. We also analyzed
CSF in 15 cases, and all of them were negative by RT-qPCR, which matches with the results of
Serrano (9 analyzed CSF, all negative) [49]. Altogether, the published data are not consistent.
The discussion of whether there is a direct brain involvement of the virus or not is open, but
our data support the hypothesis of no direct involvement. This is also supported by a system-
atic review of Li [8].
Detection of SARS-CoV-2 and correlation with histological changes
The only organ that showed a correlation between viral detection and morphological changes
was the heart. Notably, this was restricted to the epicardium, which showed mild lymphocytic
inflammation. This may have been caused by the high density of ACE-2 receptors in adipose
tissue [38, 39]. The other histological changes, especially of the myocardium, coronary arteries,
and valves, were correlates of preexisting conditions. Roshdy et al., including 316 cases over 41
studies, concluded that 1.5% of cases have myocarditis [44].
As reported above, viral RNA was detectable in other organs in varying frequencies. The
consistently mild histological changes, however, did not correlate with RT-qPCR or RNA-ISH
results but again represented preexisting conditions or could be understood as general changes
due to a critical illness. Our results validate this, especially for the kidneys, liver, and brain. The
kidney has been identified as a potential organ directly attached to the virus very early [10, 33].
Acute tubular damage is the most frequent histological change [6]. This was also noted in our
series; however, based on our experience, this was found in similar frequencies in non-COVID
autopsies. Furthermore, autopsy data alone may not be appropriate to derive this conclusion.
The renal pathophysiology in COVID-19 requires further clarification, as also stated by other
authors [46, 50]. The liver, an organ known for viral tropism and some associated characteris-
tic histopathological patterns (e.g., CMV, EBV, and hepatitis), in this study cohort did not
show any specific histological changes. Changes including mild portal chronic inflammation
and steatosis can again be assigned as preexisting or acquired due to critical illness with multi-
drug therapy. This was also shown by Schmit et al. [51] in which they described only changes
common for critically ill patients, drugs, or known preexisting diseases. By contrast, in a meta-
analysis of 116 patients, not only steatosis (55.1%) but also congestion of hepatic sinuses
(34.7%) and vascular thrombosis (29.4%) were noted [52]. Of the 19 cases, brains of 15 cases
were examined histologically. In all cases, no specific abnormalities, especially in terms of
encephalitis, was noted. This was also true in the olfactory bulb sample, which was revealed to
be positive by RT-qPCR. Only one case showed several atypical hemorrhages. It seems not pos-
sible to discriminate whether this was caused by COVID-19 or coincidental. A vasculitis or
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thromboembolic event was not found. Meinhardt et al. also identified viral RNA in approxi-
mately 10% of cases. Microthrombi and infarctions were detected in 18% of cases. Rather
infrequent changes were also reported by Solomon et al. (inflammation in 4 of 18 cases) and
Remmelink et al. (no inflammation in 11 cases) [24, 53]. Summarizing the results of several
reports up to June and November 2020, Satturwar et al. and Mukerji et al. identified focal hem-
orrhage and hypoxic changes as main findings without evidence for virus-specific inflamma-
tion [6, 54]. The very recently published systematic review by Li et al. reports the results of 28
studies with abnormalities in 134 of 202 cases. Next to hypoxic changes and vascular lesions, a
higher frequency of microgliosis/lymphatic infiltration was reported [8].
Correlation of DAD with clinical parameters
Testing with different models, diabetes was associated with a lower DAD stage, whereas male
patients presented a higher DAD stage than women. Other clinical parameters, such as age,
smoking, BMI, number of comorbidities, and length of ventilation, had no significant effect
on DAD. Diabetes in our cohort was present in 32% of the patients, which is in line with a
large cohort of 5700 COVID-19 patients from the USA with 34% [55]. This comorbidity is
associated with a higher mortality rate [56, 57]. This fact was also proven in another meta-anal-
ysis performed by Huang and colleagues [53], which showed that diabetes is associated with
severe COVID-19 and developing ARDS. In this meta-analysis, which included 30 studies, sex
did not affect the outcome, which is in contrast to our results. Altogether diabetes seems to be
a strong risk factor for a severe course of COVID-19 and a bad outcome. This could be an
explanation for the lower DAD in our cohort. Maybe patients with diabetes have a shorter
time from diagnosis to death than nondiabetic patients. A time dependency of DAD patterns
itself was published recently [58].
Limitations
The remarkable high autopsy rate of 86% and the multimethodological approach are strengths
of this study. However, there are also some limitations to mention. Although the results are rel-
atively consistent within this cohort, conclusions should be drawn only with caution due to the
small number of 19 cases from a single center. Long formalin fixing times and autolytic
changes hamper the preanalytic conditions, which makes it difficult to estimate their influence
on the results of IHC- and RNA-based analytics (to perform virus cultures was not possible for
technical limitations). Finally, this study does not include all organs and tissues that might be
of interest. This is especially true for the gastrointestinal tract. In our experience, these tissue
types are subject to pronounced autolytic changes very early after death and were therefore
excluded from further evaluations.
Another limitation concerning the comparison between the different techniques of viral
detection (RT-qPCR, RNA-ISH and ICH) is the fact the organs beside the lungs only RT-
qPCR positive samples were tested (due to the high number of samples) which could be a
selection bias. But in the lungs at least no false negative RT-qPCR results were uncovered. But
false positive RT-qPCR results could influence the calculated correlation between techniques.
Conclusion
In this study, the lungs prove to be by far the organ system most affected by COVID-19. This
is manifested at the histological level but also in the results of the various virus detection meth-
ods. Moreover, the representation of the negative sense RNA of SARS-Cov-2 here shows that
replicable virus was still present even at the time of autopsy. More so, it was the failure of the
respiratory system that led to the death of the patients. The conspicuous viral involvement of
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the mediastinal adipose tissue may support the hypothesis of a role of fat as a proinflammatory
factor postulated by other authors. In comparison, the other organ systems take a back seat.
Here, only minor to moderate changes are found, most of which are not a direct consequence
of viral damage with sufficient certainty. An indirect causality by a generalized immunological
driven event seems more likely here. This could also involve the endothelial system. Because of
the frequent reports of neurological symptoms in COVID-19 patients, we directed special
attention to the CNS, but could not detect virus-induced changes here either and detected
RNA with high Ct levels only in one case. Other methods are needed for the analysis of sys-
temic effects of COVID-19 reported by clinicians, which may be mainly at the immunological
and biochemical levels. We expect further insightful findings from currently ongoing mass
spectrometry studies in the same collective.
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